...
首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma.
【24h】

Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma.

机译:定量评估成人原发性恶性神经胶质瘤的心肺功能,骨骼肌功能和身体成分。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The study was undertaken to evaluate cardiorespiratory fitness, skeletal muscle function, and body composition of patients with newly diagnosed and untreated, postsurgical primary malignant glioma. METHODS: By using a cross-sectional design, patients with clinically stable (10 +/- 7 days postsurgery) high-grade glioma (HGG; n = 25) or low-grade glioma (LGG; n = 10) were studied. Participants performed a cardiopulmonary exercise test (CPET) with expired gas analysis to assess cardiorespiratory fitness (peak oxygen consumption, VO2peak). Other physiological outcomes included skeletal muscle cross-sectional area (CSA; magnetic resonance imaging), isokinetic muscle strength (isokinetic dynamometer), and body composition (air displacement plethysmography). Quality of life was assessed with the Functional Assessment of Cancer Therapy-Brain scale. RESULTS: CPET was a feasible and safe procedure to assess VO2peak, with no serious adverse events. VO2peak indexed to total body weight and lean body mass (LBM) for both groups was 13.0 mL x weight x min(-1) and 19 mL x LBM x min(-1), the equivalent to 59% and 38% below age- and sex-predicted normative values, respectively. Skeletal muscle strength and mid-thigh CSA were lower in HGG relative to LGG patients (83 vs 125 Nm, P = .025; 94 vs 119 cm2, P = .171, respectively). Skeletal muscle isokinetic strength, CSA, and body composition outcomes predicted VO2peak (r = -0.59 to 0.68, P < .05). CONCLUSIONS: Postsurgical glioma patients have markedly reduced cardiorespiratory fitness, isokinetic strength, and CSA. Prospective studies are now required to determine whether such abnormalities influence treatment toxicity and clinical outcome as well as to test the effect of appropriately selected interventions to prevent and/or mitigate dysfunction.
机译:背景:本研究旨在评估初诊恶性神经胶质瘤新诊断和未治疗的患者的心肺健康,骨骼肌功能和身体成分。方法:采用横断面设计,对临床稳定(术后10 +/- 7天)高级别神经胶质瘤(HGG; n = 25)或低级别神经胶质瘤(LGG; n = 10)的患者进行研究。参与者进行了带有过期气体分析的心肺运动测试(CPET),以评估心肺健康度(峰值耗氧量,VO2peak)。其他生理结果包括骨骼肌横截面积(CSA;磁共振成像),等速肌力(等速测力计)和身体成分(空气体积描记法)。生活质量用癌症治疗脑功能评估量表进行评估。结果:CPET是评估VO2peak的一种可行且安全的方法,没有严重的不良事件。两组的总体重和瘦体重(LBM)的VO2peak指数分别为13.0 mL x体重x min(-1)和19 mL x LBM x min(-1),分别相当于年龄以下的59%和38%和性别预测的规范值。相对于LGG患者,HGG的骨骼肌力量和大腿中部CSA较低(分别为83 vs 125 Nm,P = .025; 94 vs 119 cm2,P = .171)。骨骼肌等速肌力,CSA和身体成分结局可预测VO2peak(r = -0.59至0.68,P <.05)。结论:术后神经胶质瘤患者的心肺适应性,等运动强度和CSA明显降低。现在需要进行前瞻性研究以确定这些异常是否影响治疗毒性和临床结果,以及测试适当选择的干预措施预防和/或减轻功能障碍的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号